The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

199315,723 citationsJournal Article

Authors

N.K. Aaronson · The Netherlands Cancer Institute

Sam H. Ahmedzai

Bengt Bergman

Monika Bullinger · Zimmer Biomet (Germany)

A. Cull

N. Duez · European Organisation for Research and Treatment of Cancer

A. Filiberti · Fondazione IRCCS Istituto Nazionale dei Tumori

Hans‐Henning Flechtner · University of Cologne

Abstract

These results support the EORTC QLQ-C30 as a reliable and valid measure of the quality of life of cancer patients in multicultural clinical research settings. Work is ongoing to examine the performance of the questionnaire among more heterogenous patient samples and in phase II and phase III clinical trials.

Topics & Keywords

Cancer survivorship and care Head and Neck Cancer Studies Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 85, Issue 5, pp. 365-376

DOI: 10.1093/jnci/85.5.365

Field-Weighted Citation Impact: 27.69